Cellistic acquires Celyad Oncology GMP cell therapy manufacturing operations
Cellistic will invest substantial capital into the newly acquired 11,000- sq ft facility
<br />
Cellistic | 21/09/2022 | By Sudeep Soparkar | 542
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy